The stock price for Palisade Bio Inc. (PALI) currently stands at $1.81. The stock experienced a substantial increase in the last session, hitting $1.60 after starting at $1.48. The stock’s lowest price was $1.4706 before closing at $1.57.
The market performance of Palisade Bio Inc.’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $32.00 on 05/27/22, while the lowest value for the same duration was $1.41 on 05/22/23.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
52-week price history of PALI Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Palisade Bio Inc.’s current trading price is -94.34% away from its 52-week high, while its distance from the 52-week low is 28.37%. The stock’s price range during the 52-week period has remained between $1.41 and $32.00. In the Healthcare sector, the company’s shares saw a trading volume of around 2.71 million for the day, which was evidently higher than the average daily volume of 1.52 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Palisade Bio Inc. (PALI) has experienced a quarterly decline of -19.20% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.07M and boasts a workforce of 12 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.1507, with a change in price of -1.6987. Similarly, Palisade Bio Inc. recorded 2,268,706 in trading volume during the last 100 days, posting a change of -52.75%.
Examining PALI’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for PALI stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
PALI Stock Stochastic Average
Palisade Bio Inc.’s raw stochastic average for the past 50 days is presently 4.97%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 23.19%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 23.01% and 18.54%, respectively.
PALI Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -65.19%. However, over the past six months, we’ve seen a stronger performance of -18.10%. The price of PALI fallen by 17.53% over the last 30 days. And in the last five days, it has surged by 12.42%.